Pushkar Saralkar
Impact in
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
-
- Advanced Drug Delivery Systems
Papers in
-
- Brain Metastases and Treatment 2
- Co-authors
- Alekha K. Dash (1 shared paper)Werner J. Geldenhuys (8 shared papers)Samuel A. Sprowls (6 shared papers)Timothy E. Long (3 shared papers)Paul R. Lockman (6 shared papers)Tasneem Arsiwala (6 shared papers)Mark V. Pinti (4 shared papers)Afroz S. Mohammad (3 shared papers)
- Journals
- Pharmaceutical Research (2 papers)Archives of Toxicology (1 paper)Pharmaceutics (1 paper)Communications Chemistry (1 paper)European Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United StatesJapan
In The Last Decade
Pushkar Saralkar
15 papers receiving 425 citations
Peers
Comparison fields: 5 of 78
- Molecular Medicine 35
- Pharmaceutical Science 26
- Biomaterials 56
- Genetics 39
- Geriatrics and Gerontology 9
Countries citing papers authored by Pushkar Saralkar
This map shows the geographic impact of Pushkar Saralkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pushkar Saralkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pushkar Saralkar more than expected).
Fields of papers citing papers by Pushkar Saralkar
This network shows the impact of papers produced by Pushkar Saralkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pushkar Saralkar. The network helps show where Pushkar Saralkar may publish in the future.
Co-authors
The 25 scholars most cited alongside Pushkar Saralkar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 108 | |
| 2 | 2017 | 69 | |
| 3 | 2021 | 44 | |
| 4 | 2018 | 40 | |
| 5 | 2017 | 35 | |
| 6 | 2020 | 30 | |
| 7 | 2020 | 23 | |
| 8 | 2019 | 23 | |
| 9 | 2020 | 15 | |
| 10 | 2021 | 12 | |
| 11 | 2020 | 9 | |
| 12 | 2022 | 7 | |
| 13 | 2021 | 7 | |
| 14 | 2019 | 5 | |
| 15 | 2021 | 2 |
About Pushkar Saralkar
Pushkar Saralkar is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Neurology, Organic Chemistry and Oncology, having authored 15 papers that have together received 429 indexed citations. Recurring topics across this work include Barrier Structure and Function Studies (2 papers), Lung Cancer Research Studies (2 papers), Advanced Nanomaterials in Catalysis (2 papers), Brain Metastases and Treatment (2 papers), MRI in cancer diagnosis (1 paper), Mathematical Biology Tumor Growth (1 paper), Molecular Sensors and Ion Detection (1 paper) and Metabolism and Genetic Disorders (1 paper). The work is most often cited by research in Molecular Medicine (35 citations), Pharmaceutical Science (26 citations), Biomaterials (56 citations), Genetics (39 citations) and Geriatrics and Gerontology (9 citations). Pushkar Saralkar has collaborated with scholars based in United States and Japan. Frequent co-authors include Alekha K. Dash, Werner J. Geldenhuys, Samuel A. Sprowls, Timothy E. Long, Paul R. Lockman, Tasneem Arsiwala, Mark V. Pinti, Afroz S. Mohammad, Neal Shah and Brandon Lucke‐Wold. Their work appears in journals such as Pharmaceutical Research, Archives of Toxicology, Pharmaceutics, Communications Chemistry and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.